A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects

This placebo-controlled, randomised, double-blind, cross-over human feeding study aimed to determine the prebiotic effect of agave fructans. A total of thirty-eight volunteers completed this trial. The treatment consisted of 3 weeks' supplementation with 5 g/d of prebiotic agave fructan (Predil...

Full description

Bibliographic Details
Main Authors: P. Ramnani, A. Costabile, A. G. R. Bustillo, G. R. Gibson
Format: Article
Language:English
Published: Cambridge University Press 2015-01-01
Series:Journal of Nutritional Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2048679014000688/type/journal_article
_version_ 1811156017377968128
author P. Ramnani
A. Costabile
A. G. R. Bustillo
G. R. Gibson
author_facet P. Ramnani
A. Costabile
A. G. R. Bustillo
G. R. Gibson
author_sort P. Ramnani
collection DOAJ
description This placebo-controlled, randomised, double-blind, cross-over human feeding study aimed to determine the prebiotic effect of agave fructans. A total of thirty-eight volunteers completed this trial. The treatment consisted of 3 weeks' supplementation with 5 g/d of prebiotic agave fructan (Predilife) or equivalent placebo (maltodextrin), followed by a 2-week washout period following which subjects were crossed over to alternate the treatment arm for 3 weeks followed by a 2-week washout. Faecal samples were collected at baseline, on the last day of treatment (days 22 and 58) and washout (days 36 and 72), respectively. Changes in faecal bacterial populations, SCFA and secretory IgA were assessed using fluorescent in situ hybridisation, GC and ELISA, respectively. Bowel movements, stool consistencies, abdominal comfort and mood changes were evaluated by a recorded daily questionnaire. In parallel, the effect of agave fructans on different regions of the colon using a three-stage continuous culture simulator was studied. Predilife significantly increased faecal bifidobacteria (log10 9·6 (sd 0·4)) and lactobacilli (log10 7·7 (sd 0·8)) compared with placebo (log10 9·2 (sd 0·4); P = 0·00) (log10 7·4 (sd 0·7); P = 0·000), respectively. No change was observed for other bacterial groups tested, SCFA, secretory IgA, and PGE2 concentrations between the treatment and placebo. Denaturing gradient gel electrophoresis analysis indicated that bacterial communities were randomly dispersed and no significant differences were observed between Predilife and placebo treatments. The in vitro models showed similar increases in bifidobacterial and lactobacilli populations to that observed with the in vivo trial. To conclude, agave fructans are well tolerated in healthy human subjects and increased bifidobacteria and lactobacilli numbers in vitro and in vivo but did not influence other products of fermentation.
first_indexed 2024-04-10T04:44:21Z
format Article
id doaj.art-c7342468f49f4c0db7007979109c7907
institution Directory Open Access Journal
issn 2048-6790
language English
last_indexed 2024-04-10T04:44:21Z
publishDate 2015-01-01
publisher Cambridge University Press
record_format Article
series Journal of Nutritional Science
spelling doaj.art-c7342468f49f4c0db7007979109c79072023-03-09T12:38:43ZengCambridge University PressJournal of Nutritional Science2048-67902015-01-01410.1017/jns.2014.68A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjectsP. Ramnani0A. Costabile1A. G. R. Bustillo2G. R. Gibson3Department of Food and Nutritional Sciences, University of Reading, Reading RG6 6AP, UKDepartment of Food and Nutritional Sciences, University of Reading, Reading RG6 6AP, UKBustar Alimentos, SAPI de CV, Efrain Gonzalez Luna 2503, Col Arcos Sur, 44130 Guadalajara, Jalisco, MexicoDepartment of Food and Nutritional Sciences, University of Reading, Reading RG6 6AP, UKThis placebo-controlled, randomised, double-blind, cross-over human feeding study aimed to determine the prebiotic effect of agave fructans. A total of thirty-eight volunteers completed this trial. The treatment consisted of 3 weeks' supplementation with 5 g/d of prebiotic agave fructan (Predilife) or equivalent placebo (maltodextrin), followed by a 2-week washout period following which subjects were crossed over to alternate the treatment arm for 3 weeks followed by a 2-week washout. Faecal samples were collected at baseline, on the last day of treatment (days 22 and 58) and washout (days 36 and 72), respectively. Changes in faecal bacterial populations, SCFA and secretory IgA were assessed using fluorescent in situ hybridisation, GC and ELISA, respectively. Bowel movements, stool consistencies, abdominal comfort and mood changes were evaluated by a recorded daily questionnaire. In parallel, the effect of agave fructans on different regions of the colon using a three-stage continuous culture simulator was studied. Predilife significantly increased faecal bifidobacteria (log10 9·6 (sd 0·4)) and lactobacilli (log10 7·7 (sd 0·8)) compared with placebo (log10 9·2 (sd 0·4); P = 0·00) (log10 7·4 (sd 0·7); P = 0·000), respectively. No change was observed for other bacterial groups tested, SCFA, secretory IgA, and PGE2 concentrations between the treatment and placebo. Denaturing gradient gel electrophoresis analysis indicated that bacterial communities were randomly dispersed and no significant differences were observed between Predilife and placebo treatments. The in vitro models showed similar increases in bifidobacterial and lactobacilli populations to that observed with the in vivo trial. To conclude, agave fructans are well tolerated in healthy human subjects and increased bifidobacteria and lactobacilli numbers in vitro and in vivo but did not influence other products of fermentation.https://www.cambridge.org/core/product/identifier/S2048679014000688/type/journal_articleAgave fructansGut microbiotaPrebiotics
spellingShingle P. Ramnani
A. Costabile
A. G. R. Bustillo
G. R. Gibson
A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
Journal of Nutritional Science
Agave fructans
Gut microbiota
Prebiotics
title A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
title_full A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
title_fullStr A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
title_full_unstemmed A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
title_short A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
title_sort randomised double blind cross over study investigating the prebiotic effect of agave fructans in healthy human subjects
topic Agave fructans
Gut microbiota
Prebiotics
url https://www.cambridge.org/core/product/identifier/S2048679014000688/type/journal_article
work_keys_str_mv AT pramnani arandomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT acostabile arandomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT agrbustillo arandomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT grgibson arandomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT pramnani randomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT acostabile randomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT agrbustillo randomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects
AT grgibson randomiseddoubleblindcrossoverstudyinvestigatingtheprebioticeffectofagavefructansinhealthyhumansubjects